Comparison of the response using ICR mice derived from three different sources to multiple low-dose streptozotocin-induced diabetes mellitus

被引：2

作者：

Lee D.Y. ^{[1
]}

Kim M.H. ^{[1
]}

Suh H.R. ^{[1
]}

Jung Y.S. ^{[2
]}

Hwang D.Y. ^{[3
]}

Kim K.S. ^{[1
]}

机构：

[1] College of Veterinary Medicine, Kyungpook National University, 80 Daehakro, Buk-gu, Daegu

[2] Department of Pharmacy, College of Pharmacy, Pusan National University, Busan

[3] Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang

来源：

Laboratory Animal Research | 2017年 / 33卷 / 2期

关键词：

diabetes mellitus; hyperglycemia; Korl:ICR mice; multiple low-dose streptozotocin;

D O I：

10.5625/lar.2017.33.2.150

中图分类号：

学科分类号：

摘要：

This study was conducted to compare the multiple low-dose streptozotocin (MLDS)-induced diabetic patterns of Korl:ICR, A:ICR, and B:ICR mice obtained from three different sources. Six-week-old male ICR mice were obtained from three difference sources. Korl:ICR mice were kindly provided by the National Institute of Food and Drug Safety Evaluation (NIFDS). The other two groups of ICR mice were purchased from different vendors located in the United States (A:ICR) and Japan (B:ICR). All ICR mice that received MLDS exhibited overt diabetic symptoms throughout the study, and the incidence and development of diabetes mellitus were similar among the three ICR groups. The diabetic mice exhibited hyperglycemia, loss of body weight gain, decreased plasma insulin levels, impaired glucose tolerance, decreased number of insulin-positive cells, and decreased size of β-cells in the pancreas. The diabetes symptoms increased as the blood glucose level increased in the three ICR groups. In particular, the level of blood glucose in the STZ-treated group was higher in Korl:ICR and A:ICR mice than in B:ICR mice. The plasma insulin levels, glucose tolerance, blood chemistry, and morphological appearance of the pancreas were very similar in the ICR groups obtained from the three different sources. In conclusion, our results suggest that Korl:ICR, A:ICR, and B:ICR mice from different sources had similar overall responses to multiple low-dose STZ to induce diabetes mellitus. © 2017, BioMed Central Ltd.

引用

页码：150 / 156

页数：6

共 29 条

[1]

Chia R., Achilli F., Festing M.F., Fisher E.M., The origins and uses of mouse outbred stocks, Nat Genet, 37, 11, pp. 1181-1186, (2005)

[2]

Hubrecht R.C., Kirkwood J., The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals, (2010)

[3]

Vallender E.J., Miller G.M., Nonhuman primate models in the genomic era: a paradigm shift, ILAR J, 54, 2, pp. 154-165, (2013)

[4]

Fox J.G., Anderson L.C., Loew F.M., Quimby F.W., Laboratory Animal Medicine, (2002)

[5]

Cui S., Chesson C., Hope R., Genetic variation within and between strains of outbred Swiss mice, Lab Anim, 27, 2, pp. 116-123, (1993)

[6]

Lehoczky J.A., Cai W.W., Douglas J.A., Moran J.L., Beier D.R., Innis J.W., Description and genetic mapping of Polypodia: an X-linked dominant mouse mutant with ectopic caudal limbs and other malformations, Mamm Genome, 17, 9, pp. 903-913, (2006)

[7]

Al-Awar A., Kupai K., Veszelka M., Szucs G., Attieh Z., Murlasits Z., Torok S., Posa A., Varga C., Experimental Diabetes Mellitus in Different Animal Models, J Diabetes Res, 2016, (2016)

[8]

Horton E.S., NIDDM—the devastating disease, Diabetes Res Clin Pract, 28, pp. S3-S11, (1995)

[9]

Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 5, pp. 1047-1053, (2004)

[10]

Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y.H., Stevens G.A., Rao M., Ali M.K., Riley L.M., Robinson C.A., Ezzati M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million partici

← 1 2 3 →